NCT05353530 is phase I trial designed to test CD70-directed CAR-Ts applied intravenously after the end of radiotherapy in patients with newly diagnosed CD70-positive and MGMT-unmethylated glioblastoma, IDH wildtype. The gene discussed is CD70; the disease is glioblastoma.